Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | ING2 | Q9H160 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 5/20 | 0.37 |
| ▸ | CA2 | P00918 | 5/20 | 0.37 |
| ▸ | CA9 | Q16790 | 5/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | NT5E | P21589 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | SNCA | P37840 | 1/20 | 0.34 |
| ▸ | CASP6 | P55212 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1649638 | 0.83 | ING2 (0.52) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL3140050 | 0.80 | LCK (0.44) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL84322 | 0.75 | LCK (0.44) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL4730286 | 0.74 | CA1 (0.61) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL4810216 | 0.73 | NT5E (0.48) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL8367609 | 0.73 | NT5E (0.48) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL5125062 | 0.73 | LCK (0.43) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL8180623 | 0.73 | ING2 (0.42) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL219222 | 0.73 | LCK (0.57) | LCKFYNING2TSHRSMN1; SMN2 | |
| SCHEMBL8162990 | 0.72 | LCK (0.46) | LCKFYNING2TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200323986-A1 | HYDROPHOBIC ARENESULFONATE SALTS | THERACAINE LLC | 2020-10-15 | — | — | US | claimed |
| EP-3703686-A1 | HYDROPHOBIC ARENESULFONATE SALTS | Theracaine LLC (US) | 2020-09-09 | — | — | EP | claimed |
| US-20200323986-A1 | HYDROPHOBIC ARENESULFONATE SALTS | THERACAINE LLC | 2020-10-15 | — | — | US | disclosed |
| EP-3703686-A1 | HYDROPHOBIC ARENESULFONATE SALTS | Theracaine LLC (US) | 2020-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200323986-A1 | HYDROPHOBIC ARENESULFONATE SALTS | ARSA, SLC26A3, ABCB11 | LCK 2201/4885FYN 1557/4885ING2 2446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.